|
Secondary Private Group
|
|
23
|
22928
|
27 October 2019
|
|
Sacituzumab govitecan (Trodelvy)
|
|
1
|
54
|
10 December 2023
|
|
Long story and MRI advice
|
|
5
|
323
|
4 December 2023
|
|
Letrozole advantages
|
|
10
|
259
|
3 December 2023
|
|
Xeloda dosage
|
|
1
|
76
|
1 December 2023
|
|
Wbr
|
|
2
|
163
|
27 November 2023
|
|
Exemestane (aromasin) and Everolimus (Afinitor)
|
|
8
|
315
|
19 November 2023
|
|
Nearly 4 years in and brain mets. Please help
|
|
363
|
11164
|
9 November 2023
|
|
Talazoparib (Talzenna)
|
|
1
|
572
|
7 November 2023
|
|
A preference of Mastectomy Versus Lumpectomy
|
|
20
|
772
|
28 October 2023
|
|
Serious immunotherapy adverse event - Pembrolizumab
|
|
3
|
261
|
26 October 2023
|
|
News on Research
|
|
1
|
305
|
25 October 2023
|
|
Hair regrowth after wbrt
|
|
1
|
177
|
24 October 2023
|
|
New mets to brain
|
|
4
|
462
|
11 October 2023
|
|
Succesful on Capecitabine
|
|
20
|
741
|
3 October 2023
|
|
Xeloda capecitabine weight gain
|
|
4
|
192
|
1 October 2023
|
|
Potassium and White Cells
|
|
2
|
186
|
30 September 2023
|
|
Malignant Brachial Plexopathy
|
|
3
|
918
|
29 September 2023
|
|
Kidney function
|
|
10
|
389
|
28 September 2023
|
|
Bone Marrow
|
|
2
|
393
|
27 September 2023
|
|
High Neutofils?
|
|
1
|
218
|
23 September 2023
|
|
Palbociclib (ibrance) Fulvestrant (faslodex)
|
|
2
|
230
|
23 September 2023
|
|
Progression on ribociclib and letrozole
|
|
2
|
368
|
9 September 2023
|
|
Paclitaxel and bone pain and muscle pain
|
|
3
|
473
|
3 September 2023
|
|
Ribociclib QT prolongation
|
|
3
|
201
|
31 August 2023
|
|
DEXA Scan Appointment Issue
|
|
20
|
526
|
22 August 2023
|
|
Giving up on Ribociclib too soon?
|
|
5
|
566
|
10 August 2023
|
|
Very important information re sugar and hyperglycaemia!
|
|
4
|
1213
|
10 August 2023
|
|
On Kadcyla With Secondaries
|
|
3
|
429
|
24 July 2023
|
|
Alpelisib (Piqray) with fulvestrant
|
|
9
|
3853
|
24 July 2023
|